Abstract
Background and Aims: Increased plasma levels of sEng are observed in patients with cardiovascular and metabolic diseases including hypercholesterolemia, atherosclerosis, and type II diabetes mellitus, which affect liver functions and metabolism. Therefore, we hypothesized that high levels of sEng will affect cholesterol and bile acids (BA) turnover in liver.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
